Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lichter

Showing results (281-290 of 339) with videos related to

Pageof 34
Sort By:
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Blood|March 22, 2014
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trialStephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, et al.
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Haematologica|May 6, 2022
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomasCristina Lopez, Nikolai Schleussner, Stephan H Bernhart, et al.
Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Nature Medicine|June 25, 2013
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1Martje Tönjes, Sebastian Barbus, Yoon Jung Park, et al.
Pageof 34

Showing results (281-290 of 339) with videos related to

Sort By:
Pageof 34
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Blood|March 22, 2014
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trialStephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, et al.
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Haematologica|May 6, 2022
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomasCristina Lopez, Nikolai Schleussner, Stephan H Bernhart, et al.
Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Nature Medicine|June 25, 2013
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1Martje Tönjes, Sebastian Barbus, Yoon Jung Park, et al.
Pageof 34